Summit Therapeutics Inc.

Nasdaq:SMMT

Pharmaceutical Preparations·MIAMI, FL

A summit is a point on a surface that is higher in elevation than all points immediately adjacent to it. The topographic terms acme, apex, peak, and zenith are synonymous.

CEO

Zanganeh Mahkam

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	2/23/26	→
10-Q	Q3 2025	9/30/25	10/20/25	→
10-Q	Q2 2025	6/30/25	8/11/25	→
10-Q	Q1 2025	3/31/25	5/1/25	→
10-K	FY 2024	12/31/24	2/24/25	→
10-Q	Q3 2024	9/30/24	10/30/24	→
↓

Earnings Releases (8-K)

23 shown

Filed	Period
2/23/26	Q1 FY2026	→
1/12/26	Q4 FY2026	→
10/20/25	Q3 FY2025	→
8/11/25	Q3 FY2025	→
5/1/25	Q2 FY2025	→
2/24/25	Q1 FY2025	→
↓

News (8-K)

57 shown

Filed	Type	Description
1/29/26	Other	Other Events	→
11/7/25	Other	Other Events	→
10/22/25	Agreement	Entry into a Material Definitive Agreement	→
9/8/25	Other	Other Events	→
8/11/25	Agreement	Entry into a Material Definitive Agreement	→
6/20/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

35 shown

Filed	Form	Description
2/23/26	S-8	S-8	→
10/29/25	S-3ASR	S-3ASR	→
8/11/25	424B5	424B5	→
5/19/25	S-8	S-8	→
4/29/25	ARS	ARS	→
9/19/24	S-3ASR	S-3ASR	→
↓

Filing History(526 filings)

TypeDateAccessionPeriodSize

S-8

Feb 23, 2026

0001193125-26-064244S-8

—

176.1 KB

10-K

Feb 23, 2026

0001599298-26-00001510-K

Dec 31, 2025

15.6 MB

8-K

Feb 23, 2026

0001599298-26-0000148-K

Feb 23, 2026

5.9 MB

8-K

Jan 29, 2026

0001599298-26-0000068-K

Jan 29, 2026

1.4 MB

Jan 12, 2026

0001890784-26-000003FORM 4

Jan 8, 2026

5.4 KB

8-K

Jan 12, 2026

0001599298-26-0000048-K

Jan 12, 2026

5.5 MB

Jan 6, 2026

0001507650-26-000003FORM 4

Jan 2, 2026

6.3 KB

Jan 6, 2026

0001055919-26-000003FORM 4

Jan 2, 2026

5.8 KB

Jan 6, 2026

0001507567-26-000003FORM 4

Jan 2, 2026

8.1 KB

Jan 6, 2026

0001963544-26-000002FORM 4

Jan 2, 2026

5.5 KB

Jan 6, 2026

0001463740-26-000003FORM 4

Jan 2, 2026

8.0 KB

Jan 6, 2026

0001441876-26-000002FORM 4

Jan 2, 2026

5.5 KB

Jan 6, 2026

0001561736-26-000002FORM 4

Jan 2, 2026

8.1 KB

Jan 6, 2026

0001827015-26-000002FORM 4

Jan 2, 2026

8.0 KB

8-K

Nov 7, 2025

0001599298-25-0001668-K

Nov 7, 2025

2.0 MB

S-3ASR

Oct 29, 2025

0001193125-25-256643S-3ASR

—

727.4 KB

Oct 23, 2025

0001963544-25-000004FORM 4

Oct 21, 2025

5.6 KB

Oct 23, 2025

0001890784-25-000005FORM 4

Oct 21, 2025

5.2 KB

Oct 23, 2025

0001569769-25-000002FORM 4

Oct 21, 2025

5.0 KB

Oct 23, 2025

0001055919-25-000003FORM 4

Oct 21, 2025

10.0 KB

Oct 23, 2025

0001507650-25-000003FORM 4

Oct 21, 2025

10.1 KB

8-K

Oct 22, 2025

0001193125-25-2457908-K

Oct 21, 2025

490.8 KB

10-Q

Oct 20, 2025

0001599298-25-00015910-Q

Sep 30, 2025

5.3 MB

8-K

Oct 20, 2025

0001599298-25-0001568-K

Oct 17, 2025

11.9 MB

Sep 19, 2025

0001890784-25-000003FORM 4

Sep 18, 2025

5.5 KB

25 filings shown

Filed	Form	Description
4/29/25	DEF 14A	DEF 14A	→
6/13/24	DEFA14A	DEFA14A	→
4/25/24	DEF 14A	DEF 14A	→
9/19/23	DEF 14A	DEF 14A	→
9/8/23	PRE 14A	PRE 14A	→
4/21/23	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
9/26/24	D	D	→
6/18/24	D	D	→
2/27/24	EFFECT	EFFECT	→
4/27/23	EFFECT	EFFECT	→
2/3/23	EFFECT	EFFECT	→
4/14/22	CT ORDER	CT ORDER	→
↓

Summit Therapeutics Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(526 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
1/12/26	4	4	→
1/6/26	4	4	→
1/6/26	4	4	→
1/6/26	4	4	→
1/6/26	4	4	→
1/6/26	4	4	→
↓